India: AI Dominates a Strong Week for Venture Capital
India recorded $393 million across 18 deals for the week of June 13 to 19, a sharp jump from $246 million the prior week. One company was responsible for the bulk of that momentum.
- Sarvam AI: approximately $236 million (undisclosed lead investor), accounting for nearly 60% of total weekly inflow. The raise underscores growing conviction in India-built large language models designed for regional languages.
The Sarvam AI deal also lands at an inflection point for Indian venture. Deeptech funding climbed from 5% of total startup investment in 2023 to roughly 21% by 2025, a trend that suggests investors are moving beyond consumer apps and into harder, longer-horizon bets.
Europe: Growth Rounds in Fintech and Climate Tech
European deal flow remained active, with a handful of growth-stage raises standing out across fintech and sustainability.
- Festina Finance (Copenhagen): over $28 million (approximately 25 million euros), led by Birchway Capital. The company builds cloud-native modular platforms for pensions, life insurance, and financial planning.
- Solar Foods (Finland): approximately $86 million (77.8 million euros), in a package deal. The company produces protein from air using fermentation technology, positioning itself at the intersection of food security and sustainability.
Both rounds reflect continued appetite among European growth investors for B2B software and hard-science businesses that operate in regulated or infrastructure-adjacent markets.
Europe: Seed and Pre-Seed Activity
Earlier-stage activity in Europe showed breadth across climate tech, biotech, and AI-powered marketing.
- Seqana (Berlin): approximately $4 million (3.2 million euros), led by Pymwymic, with participation from HTGF and Counteract. The company quantifies soil health using satellite imagery and machine learning, targeting the carbon credit verification market.
- Houdini Bio (UK): approximately $2 million (1.7 million euros), led by SCVC, the venture arm of Science Creates. The pre-seed funds validation of a DNA sequence design platform aimed at overcoming biological barriers in gene therapies.
- Adomate (Ghent): approximately $2 million (1.4 million euros), backed by Angelwise, RDY Ventures, and Seeder Fund. The startup helps marketing teams generate social media ad creative at scale using AI.
Trends Worth Watching
The day's raises, read together, point to a few durable currents in global venture. First, foundation-model investment outside the United States is accelerating, and Sarvam AI is the clearest proof point this week. Second, European investors are directing meaningful capital toward regulated infrastructure, whether that is pension administration software or soil carbon verification, categories that require domain expertise and patient capital rather than fast consumer adoption. Third, the biotech seed market in Europe remains active even as later-stage healthcare funding has tightened, suggesting that scientific founders are finding backing at the earliest stages before clinical risk fully emerges. The convergence of AI tools and hard-science applications, visible from Seqana to Houdini Bio to Sarvam AI, is no longer a niche observation. It is becoming the default frame for how investors describe their highest-conviction bets.